MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 1 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,210 | +619.5% | 17,163 | +929.0% | 0.00% | – |
| Q2 2023 | $11,426 | +63377.8% | 1,668 | -28.8% | 0.00% | -100.0% |
| Q1 2023 | $18 | +63.6% | 2,344 | +61.0% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 1,456 | -90.2% | 0.00% | -100.0% |
| Q3 2022 | $121,000 | +72.9% | 14,820 | +104.6% | 0.00% | 0.0% |
| Q2 2022 | $70,000 | +89.2% | 7,245 | +177.1% | 0.00% | – |
| Q1 2022 | $37,000 | +311.1% | 2,615 | +471.0% | 0.00% | – |
| Q4 2021 | $9,000 | -71.0% | 458 | -66.9% | 0.00% | -100.0% |
| Q3 2021 | $31,000 | +244.4% | 1,385 | +246.2% | 0.00% | – |
| Q2 2021 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |